These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 21569331)
1. Salvianolic acids: small compounds with multiple mechanisms for cardiovascular protection. Ho JH; Hong CY J Biomed Sci; 2011 May; 18(1):30. PubMed ID: 21569331 [TBL] [Abstract][Full Text] [Related]
2. The Effect of Salvianolic Acid on Vascular Protection and Possible Mechanisms. Wu Y; Xu S; Tian XY Oxid Med Cell Longev; 2020; 2020():5472096. PubMed ID: 33062143 [TBL] [Abstract][Full Text] [Related]
3. Transformation of salvianolic acid B to salvianolic acid a in aqueous solution and the in vitro liver protective effect of the main products. Kan S; Chen Z; Shao L; Li J J Food Sci; 2014 Apr; 79(4):C499-504. PubMed ID: 24689808 [TBL] [Abstract][Full Text] [Related]
4. [Research progress of salvianolic acid A]. Zhang L; Zhang W; Zhao Y; Yang X; Fang L; Wang S; Shi L; Yu X; Wang S; Yang H; Sun J; Tian S; Du G Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(19):2603-9. PubMed ID: 22242414 [TBL] [Abstract][Full Text] [Related]
5. Isolation of salvianolic acid A, a minor phenolic carboxylic acid of Salvia miltiorrhiza. Lu L; Zhang H; Qian Y; Yuan Y Nat Prod Commun; 2010 May; 5(5):805-8. PubMed ID: 20521551 [TBL] [Abstract][Full Text] [Related]
6. Differential cardioprotective effects of salvianolic acid and tanshinone on acute myocardial infarction are mediated by unique signaling pathways. Wang X; Wang Y; Jiang M; Zhu Y; Hu L; Fan G; Wang Y; Li X; Gao X J Ethnopharmacol; 2011 Jun; 135(3):662-71. PubMed ID: 21497648 [TBL] [Abstract][Full Text] [Related]
7. Salvianolic acid B exerts vasoprotective effects through the modulation of heme oxygenase-1 and arginase activities. Joe Y; Zheng M; Kim HJ; Kim S; Uddin MJ; Park C; Ryu DG; Kang SS; Ryoo S; Ryter SW; Chang KC; Chung HT J Pharmacol Exp Ther; 2012 Jun; 341(3):850-8. PubMed ID: 22442118 [TBL] [Abstract][Full Text] [Related]
8. Investigation of the absorbed and metabolized components of Danshen from Fuzheng Huayu recipe and study on the anti-hepatic fibrosis effects of these components. Yang T; Shen DP; Wang QL; Tao YY; Liu CH J Ethnopharmacol; 2013 Jul; 148(2):691-700. PubMed ID: 23707207 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic interactions induced by content variation of major water-soluble components of Danshen preparation in rats. Chang BB; Zhang L; Cao WW; Cao Y; Yang WL; Wang Y; Chen YC; Liu XQ Acta Pharmacol Sin; 2010 May; 31(5):638-46. PubMed ID: 20364158 [TBL] [Abstract][Full Text] [Related]
10. Cerebral protection of salvianolic acid A by the inhibition of granulocyte adherence. Jiang M; Wang XY; Zhou WY; Li J; Wang J; Guo LP Am J Chin Med; 2011; 39(1):111-20. PubMed ID: 21213402 [TBL] [Abstract][Full Text] [Related]
11. Competitive inhibition of human organic anion transporters 1 (SLC22A6), 3 (SLC22A8) and 4 (SLC22A11) by major components of the medicinal herb Salvia miltiorrhiza (Danshen). Wang L; Sweet DH Drug Metab Pharmacokinet; 2013; 28(3):220-8. PubMed ID: 23229784 [TBL] [Abstract][Full Text] [Related]
12. Rosmarinic Acid Derivatives' Inhibition of Glycogen Synthase Kinase-3β Is the Pharmacological Basis of Kangen-Karyu in Alzheimer's Disease. Paudel P; Seong SH; Zhou Y; Park CH; Yokozawa T; Jung HA; Choi JS Molecules; 2018 Nov; 23(11):. PubMed ID: 30413117 [TBL] [Abstract][Full Text] [Related]
13. Salvianolic acids from antithrombotic Traditional Chinese Medicine Danshen are antagonists of human P2Y Liu X; Gao ZG; Wu Y; Stevens RC; Jacobson KA; Zhao S Sci Rep; 2018 May; 8(1):8084. PubMed ID: 29795391 [TBL] [Abstract][Full Text] [Related]
14. Alleviatory effects of Danshen, Salvianolic acid A and Salvianolic acid B on PC12 neuronal cells and Drosophila melanogaster model of Alzheimer's disease. Tan FHP; Ting ACJ; Leow BG; Najimudin N; Watanabe N; Azzam G J Ethnopharmacol; 2021 Oct; 279():114389. PubMed ID: 34217797 [TBL] [Abstract][Full Text] [Related]
15. Salvia miltiorrhiza (Danshen) injection ameliorates iron overload-induced cardiac damage in mice. Zhang JP; Zhang YY; Zhang Y; Gao YG; Ma JJ; Wang N; Wang JY; Xie Y; Zhang FH; Chu L Planta Med; 2013 Jun; 79(9):744-52. PubMed ID: 23700113 [TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacokinetic and bioavailability studies of three salvianolic acids after the administration of Salviae miltiorrhizae alone or with synthetical borneol in rats. Lai XJ; Zhang L; Li JS; Liu HQ; Liu XH; Di LQ; Cai BC; Chen LH Fitoterapia; 2011 Sep; 82(6):883-8. PubMed ID: 21575691 [TBL] [Abstract][Full Text] [Related]
17. Isolation and purification of salvianolic acid A and salvianolic acid B from Salvia miltiorrhiza by high-speed counter-current chromatography and comparison of their antioxidant activity. Sun Y; Zhu H; Wang J; Liu Z; Bi J J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Mar; 877(8-9):733-7. PubMed ID: 19237321 [TBL] [Abstract][Full Text] [Related]
18. Minor compounds of the high purity salvianolic acid B freeze-dried powder from Salvia miltiorrhiza and antibacterial activity assessment. Zhang J; Zhang X; Zhang J; Li M; Chen D; Wu T Nat Prod Res; 2018 May; 32(10):1198-1202. PubMed ID: 28475366 [TBL] [Abstract][Full Text] [Related]
19. Systematic Understanding of the Mechanism of Salvianolic Acid A via Computational Target Fishing. Chen SJ; Cui MC Molecules; 2017 Apr; 22(4):. PubMed ID: 28420179 [TBL] [Abstract][Full Text] [Related]
20. [A new method on investigate chemical constituents which have anti-thrombin effect by HPLC]. Wang JY; Hou WZ; Wei YJ; Gao SS; Bai GC; Wang AD; Ma CH Zhongguo Zhong Yao Za Zhi; 2016 Aug; 41(15):2855-2860. PubMed ID: 28914028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]